Samir Darwish

550 total citations
17 papers, 441 citations indexed

About

Samir Darwish is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Samir Darwish has authored 17 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Samir Darwish's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (5 papers). Samir Darwish is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (5 papers). Samir Darwish collaborates with scholars based in Italy, United States and Denmark. Samir Darwish's co-authors include Maurizio Tonato, Lucio Crinò, Vanesa Gregorc, Vienna Ludovini, Lorenza Pistola, Guido Bellezza, Stephen Davis, Irene Floriani, Paolo Latini and Ernesto Maranzano and has published in prestigious journals such as Cancer, CHEST Journal and Journal of Thoracic Oncology.

In The Last Decade

Samir Darwish

17 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samir Darwish Italy	12	311	250	116	88	46	17	441
Gary P. Gamble United States	7	470 1.5×	260 1.0×	177 1.5×	71 0.8×	48 1.0×	9	636
Daizo Kishino Japan	12	353 1.1×	367 1.5×	124 1.1×	31 0.4×	54 1.2×	39	555
Michel Richez Belgium	9	326 1.0×	274 1.1×	109 0.9×	19 0.2×	40 0.9×	15	422
F. Klinke Germany	8	416 1.3×	265 1.1×	61 0.5×	38 0.4×	37 0.8×	21	530
Xianghui Du China	11	167 0.5×	154 0.6×	83 0.7×	87 1.0×	27 0.6×	27	353
Sachiko Nasu Japan	11	201 0.6×	150 0.6×	86 0.7×	50 0.6×	18 0.4×	18	383
Yuko Oya Japan	14	615 2.0×	530 2.1×	134 1.2×	142 1.6×	34 0.7×	48	777
Xiangyang Yu China	15	223 0.7×	179 0.7×	95 0.8×	94 1.1×	27 0.6×	43	445
Yaping Xu China	13	358 1.2×	236 0.9×	59 0.5×	47 0.5×	19 0.4×	44	523
Teruyoshi Ishida Japan	7	235 0.8×	174 0.7×	91 0.8×	19 0.2×	14 0.3×	10	348

Countries citing papers authored by Samir Darwish

Since Specialization

Citations

This map shows the geographic impact of Samir Darwish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Darwish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Darwish more than expected).

Fields of papers citing papers by Samir Darwish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Darwish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Darwish. The network helps show where Samir Darwish may publish in the future.

Co-authorship network of co-authors of Samir Darwish

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Darwish. A scholar is included among the top collaborators of Samir Darwish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Darwish. Samir Darwish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Ludovini, Vienna, Lorenza Pistola, Vanesa Gregorc, et al.. (2008). Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology. Journal of Thoracic Oncology. 3(4). 365–373. 66 indexed citations

2.

Ludovini, Vienna, Lorenza Pistola, Vanesa Gregorc, et al.. (2008). Biological Markers and DNA Flow Cytometric Analysis in Radically Resected Patients with Non-Small Cell Lung Cancer. A Study of the Perugia Multidisciplinary Team for Thoracic Tumors. Tumori Journal. 94(3). 398–405. 11 indexed citations

3.

Ludovini, Vienna, Lorenza Pistola, Vanesa Gregorc, et al.. (2008). Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients. 1 indexed citations

4.

Ludovini, Vienna, Vanesa Gregorc, Lorenza Pistola, et al.. (2004). Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer. Lung Cancer. 46(1). 77–85. 36 indexed citations

5.

Cappuzzo, Federico, Giovanni Selvaggi, Vanesa Gregorc, et al.. (2003). Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma. Cancer. 98(1). 128–134. 34 indexed citations

6.

Maranzano, Ernesto, Lucio Crinò, Sergio Bracarda, et al.. (2002). Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer. Lung Cancer. 37(1). 79–85. 9 indexed citations

7.

Gregorc, Vanesa, Vienna Ludovini, Lorenza Pistola, et al.. (2002). Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer. 39(1). 41–48. 35 indexed citations

8.

Novello, Silvia, Luca Galli, Andrea Antonuzzo, et al.. (2001). Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. Lung Cancer. 34(2). 261–269. 4 indexed citations

9.

Lupattelli, Marco, Ernesto Maranzano, Rita Bellavita, et al.. (2000). Short-Course Palliative Radiotherapy in Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 23(1). 89–93. 39 indexed citations

10.

Cagini, Lucio, Massimo Monacelli, Giammario Giustozzi, et al.. (2000). Biological prognostic factors for early stage completely resected non-small cell lung cancer. Journal of Surgical Oncology. 74(1). 53–60. 42 indexed citations

11.

Darwish, Samir, Vincenzo Minotti, Lucio Crinò, et al.. (1995). A phase ii trial of combined chemotherapy and surgery in stage iiia non-small cell lung cancer. Lung Cancer. 12. S71–S78. 17 indexed citations

12.

Darwish, Samir, V. Minotti, Lucio Crinò, et al.. (1994). Neoadjuvant Cisplatin and Etoposide for Stage IIIA (Clinical N2) Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 17(1). 64–67. 16 indexed citations

13.

Green, Mark R., Robert J. Ginsberg, Andrea Ardizzoni, et al.. (1994). Induction therapy for Stage III NSCLC: A consensus report. Lung Cancer. 11. S9–S10. 11 indexed citations

14.

Davis, Stephen, Lucio Crinò, Maurizio Tonato, et al.. (1993). A Prospective Analysis of Chemotherapy Following Surgical Resection of Clinical Stage I-II Small-Cell Lung Cancer. American Journal of Clinical Oncology. 16(2). 93–95. 35 indexed citations

15.

Klášterský, Jean, Ronald L. Burkes, Noah C. Choi, et al.. (1991). Induction therapy for NSCLC: a consensus report. Lung Cancer. 7(1-2). 15–17. 31 indexed citations

16.

Crinò, Lucio, Maurizio Tonato, Samir Darwish, et al.. (1990). A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group. Cancer Chemotherapy and Pharmacology. 26(1). 52–56. 40 indexed citations

17.

Gerli, Roberto, et al.. (1989). Helper Inducer T Cells in the Lungs of Sarcoidosis Patients. CHEST Journal. 95(4). 811–816. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact